FOXE1 association with differentiated thyroid cancer and its progression

Thyroid

Volumn 24, Issue 5, 2014, Pages 845-851

  Penna Martinez, Marissa ^a   Epp, Friederike ^a   Kahles, Heinrich ^a   Ramos Lopez, Elizabeth ^a   Hinsch, Nora ^a   Hansmann, Martin Leo ^a   Selkinski, Ivan ^a   Grünwald, Frank ^a   Holzer, Katharina ^a   Bechstein, Wolf O ^a   Zeuzem, Stefan ^a   Vorländer, Christian ^b   Badenhoop, Klaus ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Senckenberg Institute for Pathology Goethe University Hospital Frankfurt ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

THYROID ANTIBODY; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXE1; UNCLASSIFIED DRUG; FORKHEAD TRANSCRIPTION FACTOR; FOXE1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; GENOTYPE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ADENOCARCINOMA; CARCINOMA; CELL TRANSFORMATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GERMANY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MIDDLE AGED; PATHOLOGY; SECONDARY; THYROID GLAND; THYROID TUMOR; TUMOR INVASION; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT;

ADENOCARCINOMA, FOLLICULAR; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HOSPITALS, UNIVERSITY; HUMANS; LYMPHATIC METASTASIS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POLYMORPHISM, SINGLE NUCLEOTIDE; THYROID GLAND; THYROID NEOPLASMS; YOUNG ADULT;

EID: 84901263848     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0274     Document Type: Article

References (26)

1. Aschebrook-Kilfoy B, Ward MH, Sabra MM, Devesa SS 2011 Thyroid cancer incidence patterns in the United States by histologic type, 1992-2006. Thyroid 21:125-134.
2. Agate L, Lorusso L, Elisei R 2012 New and old knowledge on differentiated thyroid cancer epidemiology and risk factors. J Endocrinol Invest 35:3-9.
3. Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Barani L, Marchi S, Ferrannini E 2007 Thyroid cancer in HCV-related chronic hepatitis patients: A case-control study. Thyroid 17:447-451. (Pubitemid 46878847)
4. Rossing MA, Voigt LF, Wicklund KG, Daling JR 2000 Reproductive factors and risk of papillary thyroid cancer in women. Am J Epidemiol 151:765-772. (Pubitemid 30461140)
5. Gomez Saez JM 2011 Diagnostic and prognostic markers in differentiated thyroid cancer. Curr Genomics 12:597-608.
6. Denny JC, Crawford DC, Ritchie MD, Bielinski SJ, Basford MA, Bradford Y, Chai HS, Bastarache L, Zuvich R, Peissig P, Carrell D, Ramirez AH, Pathak J, Wilke RA, Rasmussen L, Wang X, Pacheco JA, Kho AN, Hayes MG, Weston N, Matsumoto M, Kopp PA, Newton KM, Jarvik GP, Li R, Manolio TA, Kullo IJ, Chute CG, Chisholm RL, Larson EB, McCarty CA, Masys DR, Roden DM, de AM 2011 Variants near FOXE1 are associated with hypothyroidism and other thyroid conditions: Using electronic medical records for genome-And phenome-wide studies. Am J Hum Genet 89:529-542.
7. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464.
8. Jones AM, Howarth KM, Martin L, Gorman M, Mihai R, Moss L, Auton A, Lemon C, Mehanna H, Mohan H, Clarke SE, Wadsley J, Macias E, Coatesworth A, Beasley M, Roques T, Martin C, Ryan P, Gerrard G, Power D, Bremmer C, Tomlinson I, Carvajal-Carmona LG 2012 Thyroid cancer susceptibility polymorphisms: Confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. J Med Genet 49:158-163.
9. Matsuse M, Takahashi M, Mitsutake N, Nishihara E, Hirokawa M, Kawaguchi T, Rogounovitch T, Saenko V, Bychkov A, Suzuki K, Matsuo K, Tajima K, Miyauchi A, Yamada R, Matsuda F, Yamashita S 2011 The FOXE1 and NKX2-1 loci are associated with susceptibility to papillary thyroid carcinoma in the Japanese population. J Med Genet 48:645-648.
10. Takahashi M, Saenko VA, Rogounovitch TI, Kawaguchi T, Drozd VM, Takigawa-Imamura H, Akulevich NM, Ratanajaraya C, Mitsutake N, Takamura N, Danilova LI, Lushchik ML, Demidchik YE, Heath S, Yamada R, Lathrop M, Matsuda F, Yamashita S 2010 The FOXE1 locus is a major genetic determinant for radiation-related thyroid carcinoma in Chernobyl. Hum Mol Genet 19:2516-2523.
11. Miller SA, Dykes DD, Polesky HF 1988 A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
12. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY 1984 Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-Alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32:219-229. (Pubitemid 14184314)
13. Bland JM, Altman DG 1995 Multiple significance tests: The Bonferroni method. Br Med J 310:170.
14. Dupont WD, Plummer WD Jr 1998 Power and sample size calculations for studies involving linear regression. Control Clin Trials 19:589-601. (Pubitemid 29057724)
15. Trueba SS, Auge J, Mattei G, Etchevers H, Martinovic J, Czernichow P, Vekemans M, Polak M, Attie-Bitach T 2005 PAX8, TITF1, and FOXE1 gene expression patterns during human development: New insights into human thyroid development and thyroid dysgenesis-Associated malformations. J Clin Endocrinol Metab 90:455-462. (Pubitemid 40116694)
16. Bhattacharyya KK, Coenen MJ, Bahn RS 2005 Thyroid transcription factor-1 in orbital adipose tissues: Potential role in orbital thyrotropin receptor expression. Thyroid 15:422-426. (Pubitemid 40770620)
17. Sequeira MJ, Morgan JM, Fuhrer D, Wheeler MH, Jasani B, Ludgate M 2001 Thyroid transcription factor-2 gene expression in benign and malignant thyroid lesions. Thyroid 11:995-1001. (Pubitemid 33107910)
18. Zhang P, Zuo H, Nakamura Y, Nakamura M, Wakasa T, KakudoK2006 Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors. Pathol Int 56:240-245.
19. Cunha LL, Morari EC, Guihen AC, Razolli D, Gerhard R, Nonogaki S, Soares FA, Vassallo J, Ward LS 2012 Infiltration of a mixture of different immune cells may be related to molecular profile of differentiated thyroid cancer. Endocr Relat Cancer 19:L31-L36.
20. Tomaz RA, Sousa I, Silva JG, Santos C, Teixeira MR, Leite V, Cavaco BM 2012 FOXE1 polymorphisms are associated with familial and sporadic nonmedullary thyroid cancer susceptibility. Clin Endocrinol (Oxf) 77:926-933.
21. Kallel R, Belguith-Maalej S, Akdi A, Mnif M, Charfeddine I, Galofre P, Ghorbel A, Abid M, Marcos R, Ayadi H, Velazquez A, Hadj KH 2010 Genetic investigation of FOXE1 polyalanine tract in thyroid diseases: New insight on the role of FOXE1 in thyroid carcinoma. Cancer Biomark 8:43-51.
22. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, Leskela S, Pita G, Milne R, Maravall J, Ramos I, Andia V, Rodriguez-Poyo P, Jara-Albarran A, Meoro A, del PC, Arribas L, Iglesias P, Caballero J, Serrano J, Pico A, Pomares F, Gimenez G, Lopez-Mondejar P, Castello R, Merante-Boschin I, Pelizzo MR, Mauricio D, Opocher G, Rodriguez-Antona C, Gonzalez-Neira A, Matias-Guiu X, Santisteban P, Robledo M 2009 The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 5:e1000637.
23. Bullock M, Duncan EL, O'Neill C, Tacon L, Sywak M, Sidhu S, Delbridge L, Learoyd D, Robinson BG, Ludgate M, Clifton-Bligh RJ 2012 Association of FOXE1 polyalanine repeat region with papillary thyroid cancer. J Clin Endocrinol Metab 97:E1814-E1819.
24. Parlato R, Rosica A, Rodriguez-Mallon A, Affuso A, Postiglione MP, Arra C, Mansouri A, Kimura S, Di LR, De FM 2004 An integrated regulatory network controlling survival and migration in thyroid organogenesis. Dev Biol 276:464-475. (Pubitemid 39592407)
25. Cantara S, Capuano S, Formichi C, Pisu M, Capezzone M, Pacini F 2010 Lack of germline A339V mutation in thyroid transcription factor-1 (TITF-1/NKX2.1) gene in familial papillary thyroid cancer. Thyroid Res 3:4.
26. Jendrzejewski J, He H, Radomska HS, Li W, Tomsic J, Liyanarachchi S, Davuluri RV, Nagy R, de la Chapelle A 2012 The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci USA 109:8646-8651.